Dose-finding Study of Lenalidomide as Maintenance Therapy in Multiple Myeloma After Allogeneic Stem Cell Transplantation
Phase of Trial: Phase I/II
Latest Information Update: 14 May 2015
At a glance
- Drugs Lenalidomide (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions
- 30 Apr 2013 Status changed from recruiting to completed as reported by European Clinical Trials Database.
- 23 Jun 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2007-003784-42).
- 18 Apr 2009 Actual initiation date (Apr 2009) added as reported by ClinicalTrials.gov.